IL25 and breast carcinoma: In breast cancer, the antitumor effects of IL-17E, also namely IL-25 and a member of IL-17 family, were induced by apoptosis and infiltration of eosinophils and B cells via binding to IL‐25R on tumor cells (Gowhari Shabgah et al., 2021).